Page last updated: 2024-10-27

foscarnet and Central Nervous System Neoplasm

foscarnet has been researched along with Central Nervous System Neoplasm in 2 studies

Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marretta, L1
Stocker, H1
Drauz, D1
Mueller, M1
Masuhr, A1
Dieckmann, S1
Wong, V1
Koch, A1
Grueneisen, A1
Arastéh, K1
Weiss, R1
Aoyama, Y1
Yamamura, R1
Shima, E1
Nakamae, H1
Makita, K1
Hasegawa, T1
Sakamoto, C1
Terada, Y1
Kho, G1
Ohta, K1
Yamane, T1
Takubo, T1
Hino, M1

Other Studies

2 other studies available for foscarnet and Central Nervous System Neoplasm

ArticleYear
Treatment of HIV-related primary central nervous system lymphoma with AZT high dose, HAART, interleukin-2 and foscarnet in three patients.
    European journal of medical research, 2011, May-12, Volume: 16, Issue:5

    Topics: Adult; Antiretroviral Therapy, Highly Active; Central Nervous System Neoplasms; Foscarnet; Humans; I

2011
[Successful treatment with foscarnet for disseminated varicella-zoster infection after reduced intensity stem cell transplantation in a case of relapsed refractory central nervous system lymphoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2003, Volume: 44, Issue:7

    Topics: Acyclovir; Adult; Antiviral Agents; Central Nervous System Neoplasms; Drug Resistance, Viral; Foscar

2003